Biased Opioid Ligands
Achieving effective pain management is one of the major challenges associated with modern day medicine. Opioids, such as morphine, have been the reference treatment for moderate to severe acute pain not excluding chronic pain modalities. Opioids act through the opioid receptors, the family of G-prot...
Main Authors: | Abdelfattah Faouzi, Balazs R. Varga, Susruta Majumdar |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/18/4257 |
Similar Items
-
Pharmacological Characterization of µ-Opioid Receptor Agonists with Biased G Protein or β-Arrestin Signaling, and Computational Study of Conformational Changes during Receptor Activation
by: Justyna Piekielna-Ciesielska, et al.
Published: (2020-12-01) -
A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
by: Kendall L. Mores, et al.
Published: (2019-04-01) -
Decoding Partner Specificity of Opioid Receptor Family
by: Carlos A. V. Barreto, et al.
Published: (2021-09-01) -
Tyrosine 7.43 is important for mu-opioid receptor downstream signaling pathways activated by fentanyl
by: Xiangyun Tian, et al.
Published: (2022-09-01) -
IUPHAR themed review: Opioid efficacy, bias, and selectivity
by: Nokomis Ramos-Gonzalez, et al.
Published: (2023-11-01)